Hagen Kruger

Title: Innovations by Hagen Kruger in Cochlear Tinnitus and Hearing Loss Treatment

Introduction

Hagen Kruger is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of medical treatments, particularly focusing on cochlear tinnitus and hearing loss. With a total of 3 patents to his name, Kruger is recognized for his innovative approaches to addressing these auditory conditions.

Latest Patents

Hagen Kruger’s latest patents include groundbreaking inventions aimed at improving the quality of life for individuals suffering from auditory issues. One of his notable patents is for "1-aminocyclohexane derivatives for the treatment of cochlear tinnitus." This invention relates to administering an effective amount of a 1-amino-alkylcyclohexane derivative to individuals afflicted with cochlear tinnitus. Another significant patent focuses on "1-aminocyclohexane derivatives for the treatment of hearing loss," which involves treating individuals diagnosed with hearing loss through similar administration methods.

Career Highlights

Kruger is currently associated with Merz Pharma GmbH & Co KGaA, a company known for its commitment to developing innovative healthcare solutions. His work at Merz Pharma has allowed him to further his research and development efforts in the field of auditory health.

Collaborations

Some of Hagen Kruger’s coworkers include Barbara Ellers-Lenz and Tanja Rosenberg, who contribute to the collaborative environment that fosters innovation and research at Merz Pharma.

Conclusion

Hagen Kruger’s contributions to the treatment of cochlear tinnitus and hearing loss through his patented inventions highlight his role as a significant innovator in the medical field. His work continues to pave the way for advancements in auditory health solutions.